Motojima K
Department of Biochemistry, School of Pharmaceutical Sciences, Toho University, Funabashi, Miyama 2-2-1, Funabashi, Chiba 274-8510, Japan.
Int J Biochem Cell Biol. 2000 Oct;32(10):1085-92. doi: 10.1016/s1357-2725(00)00046-7.
The effect of a potent peroxisome proliferator-activated receptor (PPAR) alpha activator Wy14,643 on tissue-specific expression of fatty acid binding (FABP) genes was studied. Wy14,643 immediately induced liver-, intestine- and FABP but not PPARgamma-regulated adipose-FABP (or aP2) mRNAs in respective mouse tissues. Moreover, it gradually induced ectopic expression of heart- and adipose-FABP mRNAs to significant levels in the liver. However, ectopic expression was not induced in the liver of PPARalpha-null mouse, indicating an obligatory role of the receptor in the modulated expression. Among the four PPARalpha activators examined, only Wy14,643 induced ectopical expression of heart-FABP in the liver. Thus, tissue-specificity of the FABP gene expression is not absolute and, with a potent activator, can be distorted by PPARalpha.
研究了一种强效过氧化物酶体增殖物激活受体(PPAR)α激活剂Wy14,643对脂肪酸结合(FABP)基因组织特异性表达的影响。Wy14,643可立即在相应小鼠组织中诱导肝脏、肠道和FABP的mRNA表达,但不诱导PPARγ调节的脂肪FABP(或aP2)mRNA表达。此外,它还逐渐诱导心脏和脂肪FABP的mRNA在肝脏中异位表达至显著水平。然而,在PPARα基因敲除小鼠的肝脏中未诱导异位表达,这表明该受体在调节表达中起重要作用。在所检测的四种PPARα激活剂中,只有Wy14,643能诱导心脏FABP在肝脏中异位表达。因此,FABP基因表达的组织特异性并非绝对的,在强效激活剂作用下,可被PPARα改变。